Veterinary Pharmaceutical API Enrofloxacin HCl/Enrofloxacin Hydrochloride Powder
Enrofloxacin base
CAS: 93106-60-6
MF: C19H22FN3O3
Purity: 99% min
Melting range: 221ºC~226ºC
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine
Fluoroquinolonic acid:: ≤0.2%
Appearance: Light-yellow or light-yellow orange crystalline powder
Veterinary Pharmaceutical API Enrofloxacin HCl/Enrofloxacin Hydrochloride Powder
Enrofloxacin HCL is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
Enrofloxacin HCL is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs:
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.